69 related articles for article (PubMed ID: 24418698)
1. The bidirectional p53-Wrap53β promoter is controlled by common cis- and trans-regulatory elements.
Polson A; Reisman D
Gene; 2014 Mar; 538(1):138-49. PubMed ID: 24418698
[TBL] [Abstract][Full Text] [Related]
2. A bidirectional promoter reporter vector for the analysis of the p53/WDR79 dual regulatory element.
Polson A; Durrett E; Reisman D
Plasmid; 2011 Sep; 66(3):169-79. PubMed ID: 21924287
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
4. Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter.
Boggs K; Reisman D
Oncogene; 2006 Jan; 25(4):555-65. PubMed ID: 16158047
[TBL] [Abstract][Full Text] [Related]
5. ChIP (chromatin immunoprecipitation) analysis demonstrates co-ordinated binding of two transcription factors to the promoter of the p53 tumour-suppressor gene.
Polson A; Takahashi P; Reisman D
Cell Biol Int; 2010 Sep; 34(9):883-91. PubMed ID: 20446924
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a novel dual reporter vector for studying mammalian bidirectional promoters.
Léjard V; Rebours E; Meersseman C; Rocha D
Plasmid; 2014 Jul; 74():1-8. PubMed ID: 24857937
[TBL] [Abstract][Full Text] [Related]
7. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
[TBL] [Abstract][Full Text] [Related]
8. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
[TBL] [Abstract][Full Text] [Related]
10. DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis.
Schlereth K; Beinoraviciute-Kellner R; Zeitlinger MK; Bretz AC; Sauer M; Charles JP; Vogiatzi F; Leich E; Samans B; Eilers M; Kisker C; Rosenwald A; Stiewe T
Mol Cell; 2010 May; 38(3):356-68. PubMed ID: 20471942
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific modulation of the papovavirus promoters by tumor-suppressor protein p53 in the absence of large T-antigen.
Das GC; Shivakumar CV; Todd SD
Oncogene; 1995 Feb; 10(3):449-55. PubMed ID: 7845669
[TBL] [Abstract][Full Text] [Related]
12. The ASPP proteins complex and cooperate with p300 to modulate the transcriptional activity of p53.
Gillotin S; Lu X
FEBS Lett; 2011 Jun; 585(12):1778-82. PubMed ID: 21513714
[TBL] [Abstract][Full Text] [Related]
13. Major cis-regulatory elements for rice bidirectional promoter activity reside in the 5'-untranslated regions.
Dhadi SR; Deshpande A; Driscoll K; Ramakrishna W
Gene; 2013 Sep; 526(2):400-10. PubMed ID: 23756196
[TBL] [Abstract][Full Text] [Related]
14. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes.
Lohrum M; Scheidtmann KH
Oncogene; 1996 Dec; 13(12):2527-39. PubMed ID: 9000127
[TBL] [Abstract][Full Text] [Related]
16. A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.
Nagashima M; Shiseki M; Pedeux RM; Okamura S; Kitahama-Shiseki M; Miura K; Yokota J; Harris CC
Oncogene; 2003 Jan; 22(3):343-50. PubMed ID: 12545155
[TBL] [Abstract][Full Text] [Related]
17. Role of Stat3 in regulating p53 expression and function.
Niu G; Wright KL; Ma Y; Wright GM; Huang M; Irby R; Briggs J; Karras J; Cress WD; Pardoll D; Jove R; Chen J; Yu H
Mol Cell Biol; 2005 Sep; 25(17):7432-40. PubMed ID: 16107692
[TBL] [Abstract][Full Text] [Related]
18. Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoters through the epithelial specific enhancer.
Desaintes C; Hallez S; Detremmerie O; Burny A
Oncogene; 1995 Jun; 10(11):2155-61. PubMed ID: 7784059
[TBL] [Abstract][Full Text] [Related]
19. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.
Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT
Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372
[TBL] [Abstract][Full Text] [Related]
20. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
Shivakumar CV; Das GC
Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
